comparemela.com
  1. Home
  2. Live Updates
  3. Inova Study - Breaking News

Inova Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Patient Enrolled in Abiomed s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock

First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol  

United statesChuck simontonJohnson medtechColl cardiolMark bieniarzAbiomed incMexico heart instituteJapanese circulation societyDrug administrationNational cardiogenic shock initiativeUnited states foodInova studyNew mexico heart instituteNew mexico heartKansas city cardiomyopathy questionnaire

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).

United statesJohnson medtechChuck simontonMark bieniarzDrug administrationMexico heart instituteNational cardiogenic shock initiativeUnited states foodInova studyNew mexico heart instituteNew mexico heartKansas city cardiomyopathy questionnaireCardiogenic shockHealth careMyocardial infarction

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.